| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0007 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |